| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-06-02 | NCT07620275 Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA | Phase 1 | Recruiting |
| 2026-06-02 | NCT07620314 Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19… | Phase 1 | Recruiting |
| 2026-05-29 | NCT07613411 Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases | Early Phase 1 | Not Yet Recruiting |
| 2026-05-18 | NCT07592754 The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder. | Early Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT07620275 | Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA | Multiple Myeloma | Recruiting |
| NCT07620314 | Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19… | Non-Hodgkin's Lymphoma | Recruiting |
| Early Phase 1 | |||
| NCT07592754 | The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder. | Neuromyelitis Optica Spectrum Disease (NMOSD) | Not Yet Recruiting |
| NCT07613411 | Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases | Autoimmune Diseases | Not Yet Recruiting |